Clinical Trial Update: A Study of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on the evaluation of adalimumab in adult Japanese patients with rheumatoid arthritis, spanning Phase 2 and Phase 3, with the study status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Abbott | Conditions: Rheumatoid Arthritis | Phase 2, Phase 3 | Status: COMPLETED